It's that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more ...

The truth is 80% of babies under 1 year old catch RSV. “They probably mostly catch it from other children,” said Andrew Pavia, MD, Pediatric Infectious Disease at University of Utah Health/Primary ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Respiratory virus season is quickly approaching, meaning we will start to see cold, flu, COVID, and RSV in our community. The ...

The rates of respiratory syncytial virus-associated hospitalizations were three to nine times higher for assisted living residents compared with the rates for community-dwelling older adults in a ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...

Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget and issued a light sales view.